Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease

E B Mukaetova-Ladinska, F Garcia-Siera, J Hurt, H J Gertz, J H Xuereb, R Hills, C Brayne, F A Huppert, E S Paykel, M McGee, R Jakes, W G Honer, C R Harrington, C M Wischik

Research output: Contribution to journalArticle

149 Citations (Scopus)

Abstract

We have examined the relationships between dementia, loss of synaptic proteins, changes in the cytoskeleton, and deposition of beta-amyloid plaques in the neocortex in a clinicopathologically staged epidemiological cohort using a combination of biochemical and morphometric techniques. We report that loss of synaptic proteins is a late-stage phenomenon, occurring only at Braak stages 5 and 6, or at moderate to severe clinical grades of dementia, Loss of synaptic proteins was seen only after the emergence of the full spectrum of tau and beta-amyloid pathology in the neocortex at stage 4, but not in the presence of beta-amyloid plaques alone. Contrary to previous studies, we report increases in the levels of synaptophysin, syntaxin, and SNAP-25 at stage 3 and of alpha-synuclein and MAP2 at stage 4, Minimal and mild clinical grades of dementia were associated with either unchanged or elevated levels of synaptic proteins in the neocortex, Progressive aggregation of paired helical filament (PHF)-tau protein could be detected biochemically from stage 2 onwards, and this was earliest change relative to the normal aging background defined by Braak stage 1 that we were able to detect in the neocortex. These results are consistent with the possibility that failure of axonal transport associated with early aggregation of tau protein elicits a transient adaptive synaptic response to partial de-afferentation that may be mediated by trophic factors. This early abnormality in cytoskeletal function may contribute directly to the earliest clinically detectable stages of dementia.

Original languageEnglish
Pages (from-to)623-636
Number of pages14
JournalAmerican Journal of Pathology
Volume157
Issue number2
DOIs
Publication statusPublished - Aug 2000

Keywords

  • paired helical filaments
  • microtubile-associated protein-2
  • frontal-lobe degeneration
  • TAU-protein
  • monoclonal-antibodies
  • neurofibrillary tangles
  • vascular dementia
  • molecular layer
  • cerebral-cortex
  • human brain

Cite this

Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. / Mukaetova-Ladinska, E B ; Garcia-Siera, F ; Hurt, J ; Gertz, H J ; Xuereb, J H ; Hills, R ; Brayne, C ; Huppert, F A ; Paykel, E S ; McGee, M ; Jakes, R ; Honer, W G ; Harrington, C R ; Wischik, C M .

In: American Journal of Pathology, Vol. 157, No. 2, 08.2000, p. 623-636.

Research output: Contribution to journalArticle

Mukaetova-Ladinska, EB, Garcia-Siera, F, Hurt, J, Gertz, HJ, Xuereb, JH, Hills, R, Brayne, C, Huppert, FA, Paykel, ES, McGee, M, Jakes, R, Honer, WG, Harrington, CR & Wischik, CM 2000, 'Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease', American Journal of Pathology, vol. 157, no. 2, pp. 623-636. https://doi.org/10.1016/S0002-9440(10)64573-7
Mukaetova-Ladinska, E B ; Garcia-Siera, F ; Hurt, J ; Gertz, H J ; Xuereb, J H ; Hills, R ; Brayne, C ; Huppert, F A ; Paykel, E S ; McGee, M ; Jakes, R ; Honer, W G ; Harrington, C R ; Wischik, C M . / Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. In: American Journal of Pathology. 2000 ; Vol. 157, No. 2. pp. 623-636.
@article{43f7d3b6690b4631acddcb30e367f111,
title = "Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease",
abstract = "We have examined the relationships between dementia, loss of synaptic proteins, changes in the cytoskeleton, and deposition of beta-amyloid plaques in the neocortex in a clinicopathologically staged epidemiological cohort using a combination of biochemical and morphometric techniques. We report that loss of synaptic proteins is a late-stage phenomenon, occurring only at Braak stages 5 and 6, or at moderate to severe clinical grades of dementia, Loss of synaptic proteins was seen only after the emergence of the full spectrum of tau and beta-amyloid pathology in the neocortex at stage 4, but not in the presence of beta-amyloid plaques alone. Contrary to previous studies, we report increases in the levels of synaptophysin, syntaxin, and SNAP-25 at stage 3 and of alpha-synuclein and MAP2 at stage 4, Minimal and mild clinical grades of dementia were associated with either unchanged or elevated levels of synaptic proteins in the neocortex, Progressive aggregation of paired helical filament (PHF)-tau protein could be detected biochemically from stage 2 onwards, and this was earliest change relative to the normal aging background defined by Braak stage 1 that we were able to detect in the neocortex. These results are consistent with the possibility that failure of axonal transport associated with early aggregation of tau protein elicits a transient adaptive synaptic response to partial de-afferentation that may be mediated by trophic factors. This early abnormality in cytoskeletal function may contribute directly to the earliest clinically detectable stages of dementia.",
keywords = "paired helical filaments, microtubile-associated protein-2, frontal-lobe degeneration, TAU-protein, monoclonal-antibodies, neurofibrillary tangles, vascular dementia, molecular layer, cerebral-cortex, human brain",
author = "Mukaetova-Ladinska, {E B} and F Garcia-Siera and J Hurt and Gertz, {H J} and Xuereb, {J H} and R Hills and C Brayne and Huppert, {F A} and Paykel, {E S} and M McGee and R Jakes and Honer, {W G} and Harrington, {C R} and Wischik, {C M}",
year = "2000",
month = "8",
doi = "10.1016/S0002-9440(10)64573-7",
language = "English",
volume = "157",
pages = "623--636",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease

AU - Mukaetova-Ladinska, E B

AU - Garcia-Siera, F

AU - Hurt, J

AU - Gertz, H J

AU - Xuereb, J H

AU - Hills, R

AU - Brayne, C

AU - Huppert, F A

AU - Paykel, E S

AU - McGee, M

AU - Jakes, R

AU - Honer, W G

AU - Harrington, C R

AU - Wischik, C M

PY - 2000/8

Y1 - 2000/8

N2 - We have examined the relationships between dementia, loss of synaptic proteins, changes in the cytoskeleton, and deposition of beta-amyloid plaques in the neocortex in a clinicopathologically staged epidemiological cohort using a combination of biochemical and morphometric techniques. We report that loss of synaptic proteins is a late-stage phenomenon, occurring only at Braak stages 5 and 6, or at moderate to severe clinical grades of dementia, Loss of synaptic proteins was seen only after the emergence of the full spectrum of tau and beta-amyloid pathology in the neocortex at stage 4, but not in the presence of beta-amyloid plaques alone. Contrary to previous studies, we report increases in the levels of synaptophysin, syntaxin, and SNAP-25 at stage 3 and of alpha-synuclein and MAP2 at stage 4, Minimal and mild clinical grades of dementia were associated with either unchanged or elevated levels of synaptic proteins in the neocortex, Progressive aggregation of paired helical filament (PHF)-tau protein could be detected biochemically from stage 2 onwards, and this was earliest change relative to the normal aging background defined by Braak stage 1 that we were able to detect in the neocortex. These results are consistent with the possibility that failure of axonal transport associated with early aggregation of tau protein elicits a transient adaptive synaptic response to partial de-afferentation that may be mediated by trophic factors. This early abnormality in cytoskeletal function may contribute directly to the earliest clinically detectable stages of dementia.

AB - We have examined the relationships between dementia, loss of synaptic proteins, changes in the cytoskeleton, and deposition of beta-amyloid plaques in the neocortex in a clinicopathologically staged epidemiological cohort using a combination of biochemical and morphometric techniques. We report that loss of synaptic proteins is a late-stage phenomenon, occurring only at Braak stages 5 and 6, or at moderate to severe clinical grades of dementia, Loss of synaptic proteins was seen only after the emergence of the full spectrum of tau and beta-amyloid pathology in the neocortex at stage 4, but not in the presence of beta-amyloid plaques alone. Contrary to previous studies, we report increases in the levels of synaptophysin, syntaxin, and SNAP-25 at stage 3 and of alpha-synuclein and MAP2 at stage 4, Minimal and mild clinical grades of dementia were associated with either unchanged or elevated levels of synaptic proteins in the neocortex, Progressive aggregation of paired helical filament (PHF)-tau protein could be detected biochemically from stage 2 onwards, and this was earliest change relative to the normal aging background defined by Braak stage 1 that we were able to detect in the neocortex. These results are consistent with the possibility that failure of axonal transport associated with early aggregation of tau protein elicits a transient adaptive synaptic response to partial de-afferentation that may be mediated by trophic factors. This early abnormality in cytoskeletal function may contribute directly to the earliest clinically detectable stages of dementia.

KW - paired helical filaments

KW - microtubile-associated protein-2

KW - frontal-lobe degeneration

KW - TAU-protein

KW - monoclonal-antibodies

KW - neurofibrillary tangles

KW - vascular dementia

KW - molecular layer

KW - cerebral-cortex

KW - human brain

U2 - 10.1016/S0002-9440(10)64573-7

DO - 10.1016/S0002-9440(10)64573-7

M3 - Article

VL - 157

SP - 623

EP - 636

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -